Placeholder Banner

A Patient Advocate’s Perspective on Foreign Price Controls

February 7, 2020
Media Contact
Author-Profile-Andrew-Segerman

In a new video, Cynthia Bens, patient advocate and Senior Vice President of Public Policy at the Personalized Medicine Coalition, shares her views on how adopting foreign price controls for prescription medicines will impact patients in the U.S.

 

“I wouldn’t say the President’s proposal for reference pricing is the right way to deal with drug pricing issues. We need to look at the problem holistically. …
 
“What’s really challenging, right now, is all of the estimates on what the president’s foreign reference pricing proposal really means for patients is that there’s going to be a reduction in research and development. …
 
“The harms of the foreign reference pricing proposal really outweigh the benefits that patients are going to see.” 


To learn more about the flaws of importing foreign price controls, visit bio.org/save-cures.


###
 

Discover More
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a letter today urging Health and Human Services (HHS) Secretary Alex Azar to “publicly release all new guidance developed by the Food and…